Madrigal Pharmaceuticals Inc

XNAS:MDGL 4:00:00 PM EDT

427.52

+5.92 (+1.40%)

: $429.50 +1.98 (+0.46%)

Market Cap (Intraday)	9.66B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	78.3

See more stats

Estimates Current Quarter

Revenue	$244.42 Million
Adjusted EPS	-$1.97

See more estimates

10-Day MA	$428.22
50-Day MA	$433.38
200-Day MA	$346.15

See more pivots

Madrigal Pharmaceuticals Inc Stock, XNAS:MDGL

200 Barr Harbor Drive, Suite 200, West Conshohocken, Pennsylvania 19428

United States of America

Phone: +1.267.824.2827

Number of Employees: 528

http://www.madrigalpharma.com

Description

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca Taub and Edward Chiang on March 2000 and is headquartered in West Conshohocken, PA.